Intellectual Property India Publishes Patent Application for Design, Synthesis, Structural Characterization And Multi-Target Pharmacological Evaluation Of Quinoline-Piperazine Hybrid Derivatives For Simultaneous Inhibition Of Monoamine Oxidase-B, Modulation Of Dopamine D2 Receptors, Attenuation Of Tumor Necrosis Factor-Alpha Signaling And Reduction Of Oxidative Stress In Schizophrenia-Parkinsonism Disorders

MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202611090830 A) filed by Harpreet Singh; Mahalakshmi Kodadi; Bhoomi Arora; Jitendra Chobdar; Chayanika Bordoloi; Rakesh Arya; Mrunali Patel; Salahuddin; Sonia Chauhan; Neha Sharma; Kavita Rana; and Sachin Chandraket Kale on July 26, 2026, for Design, Synthesis, Structural Characterization And Multi-Target Pharmacological Evaluation Of Quinoline-Piperazine Hybrid Derivatives For Simultaneous Inhibition Of Monoamine Oxidase-B, Modulation Of Dopamine D2 Receptors, Attenuation Of Tumor Necrosis Factor-Alpha Signaling And Reduction Of Oxidative Stress In Schizophrenia-Parkinsonism Disorders.

Inventors include Harpreet Singh; Mahalakshmi Kodadi; Bhoomi Aro...